Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 09.01.2025       Newron Pharmaceuticals S.p.A.

 Newron and Myung In Pharm announce license agreementfor evenamide in South Korea Myung In Pharm to develop, manufacture and commercialize evenamide in South Korea Myung In Pharm to contribute 10% of patients to Newron’s pivotal Phase III trial for evenamide, and share global development costs Newron will receive upfront payment, development and [ … ]
Thu, 09.01.2025       Intershop Holding AG

Intershop Holding AG / Key word(s): Miscellaneous Intershop with successful December transactions 09.01.2025 / 07:00 CET/CEST A further two purchases and two disposals in December marked the end of a transaction-rich year 2024. In the 2024 financial year, a total of seven properties were purchased, six were sold and a f [ … ]
Thu, 09.01.2025       Sonova Holding AG

Sonova Holding AG / Key word(s): Personnel Sonova announces changes to its Board of Directors 09.01.2025 / 06:59 CET/CEST Group Media & Investor Release The Board of Directors (the Board) has nominated Laura Stoltenberg for election as a new member at the upcoming Annual General Meeting (AGM) in June 2025. She succe [ … ]
Thu, 09.01.2025       Redcare Pharmacy N.V.

Redcare Pharmacy completes an exceptional year across the Group: 2024 sales up 32% to EUR 2.4bn, with Rx growth in Germany accelerating to 142% in Q4. Full-year sales increase 32% year over year to EUR 2.4bn; 21% growth in non-Rx sales to EUR 1.6bn and 64% growth in total Group Rx sales to EUR 749M. In Q4, total sales rise 27% to EUR 674M; non- [ … ]
Thu, 09.01.2025       VAT Group AG

Further GROWTH IN orders and sales in Q4 2024 as recovery in Semiconductor markets continues FULL-YEAR 2024 RESULTS in line with company guidance Clara-Ann Gordon and Mike Allison nominated as new Board members, Karl Schlegel to retire from Board of Directors Based on preliminary and unaudited figures, VAT’s full-year 2024 results for orders, sal [ … ]
Thu, 09.01.2025       Trade Republic Bank GmbH

Trade Republic opens national branches in France, Spain, and Italy. 8 million customers now manage assets of over 100 billion euro. The number of customers doubled in just one year. Assets under management have reached over 100 billion euro, driven in particular by the introduction of the card and current account. The share of international custo [ … ]
Wed, 08.01.2025       Afyren SAS

AFYREN provides business update and announces a €10 million sustainable financing for its subsidiary AFYREN NEOXY AFYREN NEOXY business update : first acids sales in the second half of 2024 additional operational adjustments will be required to achieve continuous production in 2025 financial capacity strengthened by a new €10 million Sustai [ … ]
Wed, 08.01.2025       STRATEC SE

STRATEC TO PARTICIPATE IN THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE Birkenfeld, January 8, 2025 STRATEC SE, Birkenfeld, Germany, (Frankfurt: SBS; Prime Standard, SDAX) will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025, at the Westin St. Francis in San Francisco, CA, USA. Marcus Wolfinger, [ … ]
Wed, 08.01.2025       ABOUT YOU Holding SE

Hamburg, January 8, 2025 – The Chairman of the Company’s Supervisory Board, Mr. Sebastian Klauke, has today declared to the Supervisory Board and the Management Board that he will continue in his office as a member and Chairman of the Supervisory Board for a transitional period also beyond April 30, 2025. On June 3, 2024, the Company had announced [ … ]
Wed, 08.01.2025       Formycon AG

Press Release // January 8, 2025 Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® Otulfi® approved by Health Canada for both subcutaneous and intravenous formulations to treat serious inflammatory diseases Health Canada joins the FDA and the European Commission in gra [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Sunday, 23.02.2025, Calendar Week 08, 54th day of the year, 311 days remaining until EoY.